Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amerilab Technologies is a U.S.-based contract development and manufacturing organization focused on effervescent tablets, effervescent powders, and non-effervescent powder products for consumer health, nutraceutical, and related health and beauty brands. Founded in 1995 and based in Plymouth, Minnesota, the company provides turnkey services spanning formulation, product development, manufacturing, packaging, and related regulatory support. Amerilab operates as part of HBI Health & Beauty Innovations following its acquisition by DCC Health & Beauty Solutions in March 2020. The company appears to be commercially focused rather than a therapeutics developer, with capabilities centered on dosage-form innovation, scale-up, and high-volume production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amerilab Technologies.